Wednesday 6 June 2012

Fenofibrate 67 mg capsules






Fenofibrate 67mg capsules



Read all of this leaflet carefully before you start taking this medicine.


  • Keep this leaflet. You may need to read it again.

  • If you have any further questions, ask your doctor or pharmacist.

  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.



Index



  • 1 What Fenofibrate capsules are and what they are used for


  • 2 Before you take


  • 3 How to take


  • 4 Possible side effects


  • 5 How to store


  • 6 Further information




What Fenofibrate capsules are and what they are used for


Fenofibrate capsules belong to a group of medicines called lipid-regulating drugs, which lower high levels of cholesterol and other fats (lipids) including low-density lipoprotein (LDL) in the blood (hyperlipidaemia). Fenofibrate capsules
are used where a low fat diet alone is not enough.




Before you take



Do not take Fenofibrate capsules and tell your doctor if you:


  • are allergic (hypersensitive) to fenofibrate or any of the other ingredients in the capsules (see section 6).

  • have developed a sensitivity to sunlight or artificial light (e.g. sunbeds) when taking fibrates
    (e.g. fenofibrate or bezafibrate) or ketoprofen (used for muscle and bone disorders, gout or period pain).

  • have severely impaired liver or kidney function.

  • have gallbladder or liver disease.


Check with your doctor or pharmacist before taking Fenofibrate capsules if you:


  • have or have had impaired kidney function.

  • have severely increased levels of a type of fat (triglycerides) in the blood (severe hypertriglyceridaemia) (seen in a blood test).

  • have any of the following which may increase the risk of you developing abnormal muscle breakdown:
    • impaired kidney function
    • an underactive thyroid
    • a high alcohol intake
    • are over 70 years old
    • have had or have a family member with a history of hereditary muscular disorders.


  • have decreased levels of a certain protein in the blood (hypoalbuminaemia) (seen in a blood test).

  • are already taking a fibrate (e.g. bezafibrate) or a statin (e.g. atorvastatin), especially if you have muscle disease.

  • have poorly controlled diabetes mellitus (type II).

  • have nephrotic syndrome characterised by large amounts of protein in the urine, water retention and increased levels of fats in the blood.

  • have a condition which effects the amount of protein in the blood (dysproteinemia).

  • have obstructive liver disease.

  • are taking medicines which may effect fat metabolism (e.g. thiazides, beta blockers, corticosteroids or antiretrovirals).


Taking other medicines


Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Especially:


  • oral anti-coagulants e.g.warfarin (used to prevent blood clotting).

  • statins e.g. atorvastatin (used to lower cholesterol).

  • ciclosporin (used to suppress the immune system).

  • phenylbutazone (a non-steroidal anti-inflammatory drug).

  • other fibrates e.g. bezafibrate (used to lower cholesterol and other fats (lipids) in the blood).

  • oestrogen or medicines which contain oestrogen (contraceptives).



Pregnancy and breast-feeding


Fenofibrate capsules should not be used if you are pregnant or breast-feeding. Speak to your doctor before taking any medicine.




Sugar intolerance


If you have been told you have an intolerance to some sugars, contact your doctor before taking this medicine, as it contains a type of sugar called lactose.




Ingredient warning


Fenofibrate capsules contain sunset yellow (E110) which may cause allergic reactions.




Tests


Your doctor may want to carry out tests to monitor the levels of certain enzymes within your body.





How to take


Always take Fenofibrate capsules exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.


Swallow the capsules whole with water during a meal.



Doses:



Adults (including the elderly)


Three capsules a day, taken in divided doses. Your doctor will monitor your response to the treatment.



Children


One capsule a day per 20kg of bodyweight.



Impaired kidney function


If you have impaired kidney function, your doctor may prescribe you a lower dose.




If you take more than you should


If you (or someone else) swallow a lot of capsules at the same, or you think a child may have swallowed any contact your nearest hospital casualty department or tell your doctor immediately.




If you forget to take the capsules


Do not take a double dose to make up for a forgotten dose. If you forget to take a dose take it as soon as you remember it and then take the next dose at the right time.





Possible side effects


Like all medicines, Fenofibrate capsules can cause side effects, although not everybody gets them.



Stop taking Fenofibrate capsules and tell your doctor immediately if you develop:



  • Muscle poisoning: muscle pain, breakdown, inflammation, cramps or weakness, increase in the levels of a certain enzyme within the body (seen in a blood test).


Contact your doctor immediately if you develop:



  • An allergic reaction: swelling of the face, lips, tongue or throat, itchy skin rash, narrowing of the
    airways causing difficulty breathing or swallowing.


  • Hepatitis: yellowing of the skin or whites of the eyes (jaundice), itching.


Tell your doctor if you notice any of the following side effects or notice any other effects not listed:



Common (occuring in less than 1 in 10 users):


Headache, tiredness, spinning sensation, stomach or intestine disorders such as feeling or being sick, stomach pains, diarrhoea and wind. Skin rash, itching, a skin rash with pale or red irregular raised patches with severe itching, sensitivity to sunlight or artificial light (e.g. sun beds) which may include reddening of the skin, blisters or lumps.



Uncommon (occuring in less than 1 in 100 users):


Increased levels of a certain enzyme within the body (seen in a test), muscle toxicity (muscle pain, inflammation, cramps and weakness), blood clotting, inflammation of the pancreas causing stomach and back pain.



Rare (occuring in less than 1 in 1,000 users):


Disorder of the nerves causing weakness, tingling and numbness (peripheral neuropathy), hair loss, increase in blood levels of creatinine and urea, loss of sex drive, decreased levels of haemoglobin and white blood cells.


If you notice increased bruising, nosebleeds, sore throats, infections, excessive tiredness, breathlessness on exertion or abnormal paleness of the skin, you should tell your doctor who may want you to have a blood test.



Very rare (occuring in less than 1 in 10,000 users):


Lung disease (interstitial pneumopathies), inflammation of the liver (hepatitis) causing yellowing of the skin or whites of the eyes (jaundice) or tiredness, development of gallstones, abnormal muscle breakdown which can lead to kidney problems (rhabdomyolysis).


If you notice any side effects, they get worse, or if you notice any not listed, please tell your doctor or pharmacist.




How to store


Keep out of the reach and sight of children.


Do not store above 25°C.


Store in the original package.


Do not use Fenofibrate capsules after the expiry date stated on the label/carton/bottle. The expiry date refers to the last day of that month.


Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.




Further information



What Fenofibrate capsules contain


  • The active substance (the ingredient that makes the capsules work) is micronised fenofibrate. Each capsule contains 67mg of the active substance.

  • The other ingredients are lactose monohydrate, pregelatinised starch, sodium lauryl sulphate, povidone, magnesium stearate, gelatin, titanium dioxide (E171), quinolone yellow (E104), sunset yellow (E110).



What Fenofibrate capsules look like and contents of the pack


Fenofibrate capsules are yellow, hard, gelatin capsules.


Pack size is 90.




Marketing Authorisation Holder and Manufacturer



Actavis

Barnstaple

EX32 8NS

UK



This leaflet was last revised in January 2010.



If you would like a leaflet with larger text, please contact 01271 311257.




Actavis

Barnstaple

EX32 8NS

UK


50329963





No comments:

Post a Comment